← Back to Patent Explorer
US4297362A Expired / Lapsed US ⏱️ 0.0 years remaining

4-(3,4-Diaminophenyl)pyridine or salts, and use thereof as cardiotonic

Assignee: Sanofi SA
•
Filing: 1980-07-28
•
Granted: 1981-10-27
•
Expires: 2000-07-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 4-(3,4-Diaminophenyl)pyridine, a cardiotonic agent, is prepared by reducing 4-(4-amino-3-nitrophenyl)pyridine or preferably by reacting 4-(4-acetylamino-3-nitrophenyl)pyridine or 4-(3-acetylamino-4-nitrophenyl)pyridine with stannous chloride and hydrochloric acid. 4-(3,4-diaminophenyl)pyridine or pharmaceutically-acceptable acid-addition salt thereof is disclosed as the active ingredient in a cardiotonic composition for increasing cardiac contractility and in the method for increasing cardiac contractility in a patient requiring such treatment.

Inventors

  • 👤 George Y. Lesher
  • 👤 Baldev Singh

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 09:44
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/36; C07D213/40; C07D213/38

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 6 words
4-(3,4-Diaminophenyl)pyridine or pharmaceutically-acceptable acid-addition salt thereof.
Claim 2
Dependent Claim 6 words
4-(3,4-Diaminophenyl)pyridine or pharmaceutically-acceptable acid-addition salt thereof.
Claim 3
Dependent Claim 1 words
4-(3,4-Diaminophenyl)pyridine.
Claim 4
Dependent Claim 1 words
4-(3,4-Diaminophenyl)pyridine.
Claim 5
Dependent Claim 32 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of the cardiotonic 4-(3,4-diaminophenyl)pyridine or pharmaceutically-acceptable acid-addition salt thereof.
Claim 6
Dependent Claim 32 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of the cardiotonic 4-(3,4-diaminophenyl)pyridine or pharmaceutically-acceptable acid-addition salt thereof.
Claim 7
Dependent Claim 12 words
A composition according to claim 3 where the active component is 4-(3,4-diaminophenyl)pyridine.
Claim 8
Independent Claim 36 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering parenterally in a liquid dosage form to such patient an effective amount of the cardiotonic 4-(3,4-diaminiphenyl)pyridine or pharmaceutically-acceptable acid-acceptable salt thereof.
Claim 9
Independent Claim 36 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering parenterally in a liquid dosage form to such patient an effective amount of the cardiotonic 4-(3,4-diaminiphenyl)pyridine or pharmaceutically-acceptable acid-acceptable salt thereof.

References Cited (Backward Citations)

US3891656A Cited
US3994903A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-26 1985-04-27 1985-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-26 1989-04-27 1989-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-26 1993-04-27 1993-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag